Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer
- 31 August 1994
- Vol. 44 (2) , 215-220
- https://doi.org/10.1016/s0090-4295(94)80134-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evaluation of the current incidence of nodal metastasis from prostate cancerJournal of Surgical Oncology, 1993
- Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor gradeUrology, 1993
- Pelvic lymphadenectomy for staging clinically localized prostate cancer Indications, Complications, and Results in 217 CasesUrology, 1990
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. I. Untreated PatientsJournal of Urology, 1989
- Correlation of Clinical Stage, Serum Prostatic Acid Phosphatase and Preoperative Gleason Grade with Final Pathological Stage in 275 Patients with Clinically Localized Adenocarcinoma of the ProstateJournal of Urology, 1987
- Prediction of Lymphatic Metastases by Gleason Histologic Grading in Prostatic CancerJournal of Urology, 1982
- Prognosis of Patients With Stage D1 Prostatic AdenocarcinomaJournal of Urology, 1981
- Predictors of Lymphatic Spread in Prostatic Adenocarcinoma: Uro-Oncology Research Group StudyJournal of Urology, 1980
- Sodium Thymolphthalein Monophosphate: A New Acid Phosphatase Substrate with Greater Specificity for the Prostatic Enzyme in SerumClinical Chemistry, 1971
- Lymphatic Spread from Prostatic CancerJournal of Urology, 1959